Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin

Meng-Zhu Yao,1 Ming-Yi Huang-Fu,1 Hui-Na Liu,1 Xia-Rong Wang,1 Xiaoxia Sheng,2 Jian-Qing Gao1 1Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 2Hangzhou SoliPharma Co., Ltd, Hangzhou, Zhejiang, People’s Republic of China Abstract: Nano-hydroxyapatite/...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yao MZ, Huang-Fu MY, Liu HN, Wang XR, Sheng XX, Gao JQ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/f73bc4e056e14ee3a49c179889f970a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f73bc4e056e14ee3a49c179889f970a7
record_format dspace
spelling oai:doaj.org-article:f73bc4e056e14ee3a49c179889f970a72021-12-02T02:06:52ZFabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin1178-2013https://doaj.org/article/f73bc4e056e14ee3a49c179889f970a72016-11-01T00:00:00Zhttps://www.dovepress.com/fabrication-and-characterization-of-drug-loaded-nano-hydroxyapatitepol-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Meng-Zhu Yao,1 Ming-Yi Huang-Fu,1 Hui-Na Liu,1 Xia-Rong Wang,1 Xiaoxia Sheng,2 Jian-Qing Gao1 1Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 2Hangzhou SoliPharma Co., Ltd, Hangzhou, Zhejiang, People’s Republic of China Abstract: Nano-hydroxyapatite/polyamide 66 (nHA/PA66) porous scaffolds were fabricated by a phase inversion method. Carbon nanotubes (CNTs) and silk fibroin (SF) were used to modify the surface of the nHA/PA66 scaffolds by freeze-drying and cross-linking. Dexamethasone was absorbed to the CNTs to promote the osteogenic differentiation of bone mesenchymal stem cells (BMSCs). The cell viability of BMSCs was investigated by changing the concentration of the CNT dispersion, and the most biocompatible scaffold was selected. In addition, the morphology and mechanical property of the scaffolds were investigated. The results showed that the nHA/PA66 scaffolds modified with CNTs and SF met the requirements of bone tissue engineering scaffolds. The dexamethasone-loaded CNT/SF-nHA/PA66 composite scaffold promoted the osteogenic differentiation of BMSCs, and the drug-loaded scaffolds are expected to function as effective bone tissue engineering scaffolds. Keywords: BMSCs, tissue engineering, porous scaffold, carbon nanotubes, silk fibroin, surface modification, dexamethasoneYao MZHuang-Fu MYLiu HNWang XRSheng XXGao JQDove Medical Pressarticletissue engineeringnano-hydroxyapatitepolyamide 66porous scaffoldcarbon nanotubessilk fibroinsurface modificationdexamethasoneMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 6181-6194 (2016)
institution DOAJ
collection DOAJ
language EN
topic tissue engineering
nano-hydroxyapatite
polyamide 66
porous scaffold
carbon nanotubes
silk fibroin
surface modification
dexamethasone
Medicine (General)
R5-920
spellingShingle tissue engineering
nano-hydroxyapatite
polyamide 66
porous scaffold
carbon nanotubes
silk fibroin
surface modification
dexamethasone
Medicine (General)
R5-920
Yao MZ
Huang-Fu MY
Liu HN
Wang XR
Sheng XX
Gao JQ
Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
description Meng-Zhu Yao,1 Ming-Yi Huang-Fu,1 Hui-Na Liu,1 Xia-Rong Wang,1 Xiaoxia Sheng,2 Jian-Qing Gao1 1Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 2Hangzhou SoliPharma Co., Ltd, Hangzhou, Zhejiang, People’s Republic of China Abstract: Nano-hydroxyapatite/polyamide 66 (nHA/PA66) porous scaffolds were fabricated by a phase inversion method. Carbon nanotubes (CNTs) and silk fibroin (SF) were used to modify the surface of the nHA/PA66 scaffolds by freeze-drying and cross-linking. Dexamethasone was absorbed to the CNTs to promote the osteogenic differentiation of bone mesenchymal stem cells (BMSCs). The cell viability of BMSCs was investigated by changing the concentration of the CNT dispersion, and the most biocompatible scaffold was selected. In addition, the morphology and mechanical property of the scaffolds were investigated. The results showed that the nHA/PA66 scaffolds modified with CNTs and SF met the requirements of bone tissue engineering scaffolds. The dexamethasone-loaded CNT/SF-nHA/PA66 composite scaffold promoted the osteogenic differentiation of BMSCs, and the drug-loaded scaffolds are expected to function as effective bone tissue engineering scaffolds. Keywords: BMSCs, tissue engineering, porous scaffold, carbon nanotubes, silk fibroin, surface modification, dexamethasone
format article
author Yao MZ
Huang-Fu MY
Liu HN
Wang XR
Sheng XX
Gao JQ
author_facet Yao MZ
Huang-Fu MY
Liu HN
Wang XR
Sheng XX
Gao JQ
author_sort Yao MZ
title Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
title_short Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
title_full Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
title_fullStr Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
title_full_unstemmed Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
title_sort fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/f73bc4e056e14ee3a49c179889f970a7
work_keys_str_mv AT yaomz fabricationandcharacterizationofdrugloadednanohydroxyapatitepolyamide66scaffoldsmodifiedwithcarbonnanotubesandsilkfibroin
AT huangfumy fabricationandcharacterizationofdrugloadednanohydroxyapatitepolyamide66scaffoldsmodifiedwithcarbonnanotubesandsilkfibroin
AT liuhn fabricationandcharacterizationofdrugloadednanohydroxyapatitepolyamide66scaffoldsmodifiedwithcarbonnanotubesandsilkfibroin
AT wangxr fabricationandcharacterizationofdrugloadednanohydroxyapatitepolyamide66scaffoldsmodifiedwithcarbonnanotubesandsilkfibroin
AT shengxx fabricationandcharacterizationofdrugloadednanohydroxyapatitepolyamide66scaffoldsmodifiedwithcarbonnanotubesandsilkfibroin
AT gaojq fabricationandcharacterizationofdrugloadednanohydroxyapatitepolyamide66scaffoldsmodifiedwithcarbonnanotubesandsilkfibroin
_version_ 1718402749022863360